| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunitybio, Inc. (IBRX) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. IBRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 29.82M | $251.24M | - | |
| CEO | 548.2K | $4.62M | - | |
| CFO | 322.8K | $2.72M | - | |
| Dir | 162.8K | $1.37M | - | |
| Dir | 162.8K | $1.37M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2021 | Nelson Sonja | Chief Financial Officer | Sale+OE | 16,364 | $15.00 | $245,460.00 | -51.5% | |
| Jan 4, 2021 | Nelson Sonja | Chief Financial Officer | Sale+OE | 39,271 | $13.62 | $534,937.78 | -65.8% | |
| Dec 22, 2020 | Simon Barry J.79 | See Remarks | Sale+OE | 130,000 | $18.05 | $2,346,604.00 | -3.9% | |
| Dec 10, 2020 | Thomas John C | Director | Sell | 42,592 | $10.83 | $461,122.29 | -17.0% | |
| Aug 19, 2020 | Thomas John C | Director | Sell | 20,000 | $9.19 | $183,800.00 | -7.4% | |
| Aug 13, 2020 | Thomas John C | Director | Sell | 60,000 | $9.73 | $583,642.00 | -4.8% | |
| Aug 11, 2020 | Cohen Cheryl77 | Director | Sell | 30,000 | $9.96 | $298,785.00 | -10.0% | |
| Aug 11, 2020 | Driscoll Frederick W | Director | Sell | 65,300 | $10.23 | $668,051.57 | -15.8% | |
| Jul 21, 2020 | Simon Barry J.79 | See Remarks | Sale+OE | 130,000 | $15.53 | $2,019,328.89 | -2.0% | |
| Jul 8, 2020 | Simon Barry J.79 | See Remarks | Sale+OE | 39,950 | $13.14 | $524,759.23 | -1.2% |